AnaptysBio
(NASDAQ:ANAB)
$21.93
0.55[2.57%]
Last update: 11:25AM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$0.00
Lowest Price Target1
$0.00
Consensus Price Target1
$35.67

AnaptysBio Stock (NASDAQ:ANAB), Analyst Ratings, Price Targets, Predictions

AnaptysBio Inc has a consensus price target of $35.67, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from Wedbush, BTIG, and Stifel on March 12, 2024, February 26, 2024, and February 21, 2024. With an average price target of $35 between Wedbush, BTIG, and Stifel, there's an implied 59.60% upside for AnaptysBio Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
3
Feb
3
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wedbush
BTIG
Stifel
Piper Sandler
UBS

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for AnaptysBio

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/12/2024ANABBuy Now
AnaptysBio
$21.93Wedbush
David Nierengarten
$20 → $34UpgradeNeutral → OutperformGet Alert
02/26/2024ANABBuy Now
AnaptysBio
$21.93150.8%BTIG
Julian Harrison
→ $55Initiates → BuyGet Alert
02/21/2024ANABBuy Now
AnaptysBio
$21.93128%Stifel
Alex Schwartz
→ $50Initiates → BuyGet Alert
02/16/2024ANABBuy Now
AnaptysBio
$21.93264.8%Piper Sandler
Yasmeen Rahimi
→ $80Initiates → OverweightGet Alert
11/29/2023ANABBuy Now
AnaptysBio
$21.93-8.8%Wedbush
David Nierengarten
→ $20ReiteratesNeutral → NeutralGet Alert
11/03/2023ANABBuy Now
AnaptysBio
$21.93-8.8%Wedbush
David Nierengarten
$18 → $20MaintainsNeutralGet Alert
11/02/2023ANABBuy Now
AnaptysBio
$21.93-4.24%UBS
Eliana Merle
$28 → $21MaintainsNeutralGet Alert
08/08/2023ANABBuy Now
AnaptysBio
$21.9318.56%Wedbush
David Nierengarten
$29 → $26MaintainsNeutralGet Alert
05/22/2023ANABBuy Now
AnaptysBio
$21.9336.8%JP Morgan
Anupam Rama
$31 → $30UpgradeUnderweight → NeutralGet Alert
05/12/2023ANABBuy Now
AnaptysBio
$21.9332.24%Wedbush
David Nierengarten
→ $29ReiteratesNeutral → NeutralGet Alert
05/12/2023ANABBuy Now
AnaptysBio
$21.93105.2%Guggenheim
Yatin Suneja
$44 → $45MaintainsBuyGet Alert
04/12/2023ANABBuy Now
AnaptysBio
$21.9341.36%JP Morgan
Anupam Rama
$32 → $31MaintainsUnderweightGet Alert
01/06/2023ANABBuy Now
AnaptysBio
$21.93Raymond James
Timur Ivannikov
DowngradeOutperform → Market PerformGet Alert
11/18/2022ANABBuy Now
AnaptysBio
$21.9345.92%JP Morgan
Anupam Rama
$24 → $32MaintainsUnderweightGet Alert
11/09/2022ANABBuy Now
AnaptysBio
$21.9373.28%Raymond James
Steven Seedhouse
$30 → $38MaintainsOutperformGet Alert
11/01/2022ANABBuy Now
AnaptysBio
$21.93Guggenheim
Yatin Suneja
UpgradeNeutral → BuyGet Alert
09/19/2022ANABBuy Now
AnaptysBio
$21.9359.6%HC Wainwright & Co.
Gobind Singh
→ $35Assumes → BuyGet Alert
09/13/2022ANABBuy Now
AnaptysBio
$21.9327.68%Truist Securities
John Lee
$50 → $28DowngradeBuy → HoldGet Alert
09/01/2022ANABBuy Now
AnaptysBio
$21.9359.6%Raymond James
Steven Seedhouse
→ $35Initiates → OutperformGet Alert

FAQ

Q

What is the target price for AnaptysBio (ANAB)?

A

The latest price target for AnaptysBio (NASDAQ: ANAB) was reported by Wedbush on March 12, 2024. The analyst firm set a price target for $0.00 expecting ANAB to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for AnaptysBio (ANAB)?

A

The latest analyst rating for AnaptysBio (NASDAQ: ANAB) was provided by Wedbush, and AnaptysBio upgraded their outperform rating.

Q

When was the last upgrade for AnaptysBio (ANAB)?

A

The last upgrade for AnaptysBio Inc happened on March 12, 2024 when Wedbush raised their price target to N/A. Wedbush previously had a neutral for AnaptysBio Inc.

Q

When was the last downgrade for AnaptysBio (ANAB)?

A

The last downgrade for AnaptysBio Inc happened on January 6, 2023 when Raymond James changed their price target from N/A to N/A for AnaptysBio Inc.

Q

When is the next analyst rating going to be posted or updated for AnaptysBio (ANAB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AnaptysBio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AnaptysBio was filed on March 12, 2024 so you should expect the next rating to be made available sometime around March 12, 2025.

Q

Is the Analyst Rating AnaptysBio (ANAB) correct?

A

While ratings are subjective and will change, the latest AnaptysBio (ANAB) rating was a upgraded with a price target of $0.00 to $0.00. The current price AnaptysBio (ANAB) is trading at is $21.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch